Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.

Crotta S, Brazzoli M, Piccioli D, Valiante NM, Wack A.

J Hepatol. 2010 Feb;52(2):183-90. doi: 10.1016/j.jhep.2009.11.003. Epub 2009 Dec 16.

PMID:
20015567
2.

Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.

Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, Abrignani S, Valiante NM.

J Exp Med. 2002 Jan 7;195(1):35-41.

3.

Natural killer cells inhibit hepatitis C virus expression.

Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ.

J Leukoc Biol. 2004 Dec;76(6):1171-9. Epub 2004 Aug 31.

PMID:
15339939
4.
5.

Activation of natural killer cells by hepatitis C virus particles in vitro.

Farag MM, Weigand K, Encke J, Momburg F.

Clin Exp Immunol. 2011 Sep;165(3):352-62. doi: 10.1111/j.1365-2249.2011.04431.x. Epub 2011 Jun 17.

6.

Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Yoon JC, Lim JB, Park JH, Lee JM.

J Virol. 2011 Dec;85(23):12557-69. doi: 10.1128/JVI.00838-11. Epub 2011 Sep 21.

7.

CD27 engagement by a soluble CD70 protein enhances non-cytolytic antiviral activity of CD56bright natural killer cells by IFN-γ secretion.

Jang YS, Kang W, Chang DY, Sung PS, Park BC, Yoo SH, Park YW, Shin EC.

Clin Immunol. 2013 Dec;149(3):379-87. doi: 10.1016/j.clim.2013.09.007. Epub 2013 Sep 26.

PMID:
24211844
8.

Hepatitis C virus (HCV): a review of immunological aspects.

Irshad M, Khushboo I, Singh S, Singh S.

Int Rev Immunol. 2008;27(6):497-517. doi: 10.1080/08830180802432178. Review.

PMID:
19065353
9.

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Jul-Aug;157(4):377-86. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):207.

PMID:
17051976
10.

[Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].

Pár G, Berki T, Pálinkás L, Balogh P, Szereday L, Halász M, Szekeres-Barthó J, Miseta A, Hegedus G, Mózsik G, Hunyady B, Pár A.

Orv Hetil. 2006 Apr 2;147(13):591-600. Hungarian.

PMID:
16623441
11.

CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.

D'Agosto G, Trento E, Nosotti L, Bordignon V, Battista M, Prignano G, Pimpinelli F, Biolcati G, Macrì A, Palamara G, Miglioresi L, Morrone A, Di Carlo A, Cordiali-Fei P, Ensoli F.

J Biol Regul Homeost Agents. 2009 Jul-Sep;23(3):155-64.

PMID:
19828092
12.

Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells.

Crotta S, Ronconi V, Ulivieri C, Baldari CT, Valiante NM, Abrignani S, Wack A.

Eur J Immunol. 2006 Apr;36(4):919-29. Erratum in: Eur J Immunol. 2006 May;36(5):1350. Valiente, Nicholas M [corrected to Valiante, Nicholas M].

13.

IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.

Zhang S, Saha B, Kodys K, Szabo G.

J Hepatol. 2013 Sep;59(3):442-9. doi: 10.1016/j.jhep.2013.04.022. Epub 2013 May 7.

14.

Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.

Nattermann J, Nischalke HD, Feldmann G, Ahlenstiel G, Sauerbruch T, Spengler U.

J Viral Hepat. 2004 Nov;11(6):519-26.

PMID:
15500552
15.

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

Yoon JC, Shiina M, Ahlenstiel G, Rehermann B.

Hepatology. 2009 Jan;49(1):12-21. doi: 10.1002/hep.22624.

16.

Lymphocyte distribution and intrahepatic compartmentalization during HCV infection: a main role for MHC-unrestricted T cells.

Agrati C, Nisii C, Oliva A, D'Offizi G, Montesano C, Pucillo LP, Poccia F.

Arch Immunol Ther Exp (Warsz). 2002;50(5):307-16. Review.

PMID:
12455864
17.

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.

Jinushi M, Takehara T, Kanto T, Tatsumi T, Groh V, Spies T, Miyagi T, Suzuki T, Sasaki Y, Hayashi N.

J Immunol. 2003 Feb 1;170(3):1249-56.

18.

Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA.

J Immunol. 1999 Apr 15;162(8):4511-20.

19.

NK cells prevalence, subsets and function in viral hepatitis C.

Zeromski J, Mozer-Lisewska I, Kaczmarek M, Kowala-Piaskowska A, Sikora J.

Arch Immunol Ther Exp (Warsz). 2011 Dec;59(6):449-55. doi: 10.1007/s00005-011-0145-y. Epub 2011 Oct 5. Review.

PMID:
21972016
20.

Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.

Wellnitz S, Klumpp B, Barth H, Ito S, Depla E, Dubuisson J, Blum HE, Baumert TF.

J Virol. 2002 Feb;76(3):1181-93.

Supplemental Content

Support Center